Patrice Matchaba, Novartis
„The value balancing alliance aims to standardize impact valuation. We believe standardization is required in order to drive broader adoption and will ultimately serve stakeholders – including shareholders and governments – helping to effectively compare non-financial performance among companies. At Novartis, we have developed and tested our approach to Financial, Environmental and Social (FES) impact valuation, and we are interested in sharing our experience and exchanging with other like-minded companies to help evolve it further.“